novel
twostep
realtim
rtpcr
assay
use
sybr
green
develop
detect
acut
bovin
viral
diarrhoea
viru
bvdv
infect
whole
blood
cattl
infect
anim
experi
characterist
transient
leucopenia
number
cell
per
volum
blood
chang
time
quantit
viral
load
refer
cellular
housekeep
gene
ideal
may
hide
signific
anim
anim
variat
therefor
facilit
comparison
differ
sampl
extern
rna
refer
use
normalis
wherebi
sampl
spike
rna
viru
canin
enter
coronaviru
cecov
prior
rna
extract
compar
purpos
realtim
rtpcr
carri
two
primer
set
design
amplifi
either
bp
region
bvdv
utr
bp
region
cecov
nucleocapsid
protein
gene
linear
effici
assay
establish
method
assess
use
sampl
bvdvchalleng
calv
viral
rna
quantifi
day
postchalleng
realtim
rtpcr
infecti
viru
isol
tradit
cell
cultur
neg
day
studi
demonstr
encourag
result
rapid
sensit
reliabl
detect
acut
bvdv
infect
provid
altern
realtim
rtpcr
method
use
whole
blood
sampl
sampl
suitabl
housekeep
gene
avail
bovin
viral
diarrhoea
viru
bvdv
pathogen
worldwid
import
cattl
caus
signific
econom
loss
brownli
bvdv
classifi
within
pestiviru
genu
flavivirida
heinz
et
al
pestivirus
small
envelop
virus
contain
singlestrand
posit
sens
rna
molecul
approxim
kb
genom
transcrib
singl
open
read
frame
flank
untransl
region
utr
bvdv
polyprotein
coand
posttransl
cleav
give
rise
number
viral
structur
nonstructur
protein
collett
et
al
acut
bvdv
infect
often
clinic
unappar
mild
clinic
sign
includ
transient
pyrexia
leucopenia
oculonas
discharg
depress
although
frequent
unnot
acut
infect
contribut
caus
varieti
problem
includ
diseas
reproduct
respiratori
enter
system
baker
bvdv
infect
pregnanc
may
result
foetal
infect
foetus
infect
onset
immunocompet
becom
persist
infect
persist
infect
pi
anim
continu
shed
viru
act
major
reservoir
infect
cattl
paton
et
al
current
laboratorybas
bvdv
detect
method
includ
serolog
assay
viru
isol
antigen
detect
detect
viral
rna
revers
transcript
rt
pcr
sandvik
realtim
pcr
use
identifi
classifi
quantifi
mani
viral
pathogen
highli
sensit
rapid
method
detect
viral
nucleic
acid
sequenc
clinic
specimen
furthermor
realtim
pcr
quantit
techniqu
may
use
assess
viral
rna
level
realtim
rtpcr
method
genotyp
bvdv
describ
previous
weinstock
lettelli
kerkhof
paper
focus
detect
classif
bvdv
either
two
recognis
genotyp
rather
monitor
chang
viral
load
cours
acut
persist
infect
howev
realtim
pcr
quantit
techniqu
may
also
use
assess
viral
rna
level
cours
infect
recoveri
use
realtim
pcr
quantifi
viral
rna
level
bvdvinfect
anim
present
particular
technic
biolog
challeng
collect
process
sampl
differ
anim
number
differ
day
inevit
result
degre
sampl
sampl
variat
technic
detect
target
nucleic
acid
aris
differ
effici
rna
extract
revers
transcript
pcr
reaction
made
particularli
signific
sensit
techniqu
technic
variat
often
control
normalis
signal
intern
standard
typic
housekeep
gene
facilit
comparison
differ
data
set
present
two
problem
firstli
whilst
common
practic
housekeep
gene
rare
truli
static
may
alter
experiment
condit
thellin
et
al
whelan
et
al
take
account
best
practic
would
recommend
assess
valid
number
differ
housekeep
gene
target
compar
test
condit
use
labori
task
way
object
identifi
stabl
mrna
set
howev
process
relev
bvdv
situat
infect
secondli
acut
infect
bvdv
anim
experi
measur
leucopenia
number
cell
per
volum
blood
chang
time
tradit
method
viru
isol
quantit
amount
viru
recov
fix
volum
blood
irrespect
cell
number
sampl
acut
bvdv
infect
fluctuat
polak
zmudzinski
standardis
viral
rna
measur
realtim
pcr
housekeep
gene
set
quantit
essenti
done
per
cell
basi
rather
per
volum
basi
render
comparison
sampl
leucopen
calv
difficult
preclud
simpl
comparison
tradit
virolog
method
overcom
difficulti
novel
twostep
realtim
rtpcr
method
use
extern
rna
refer
standard
develop
evalu
sampl
experiment
infect
cattl
sampl
spike
known
amount
second
rna
viru
canin
enter
coronaviru
cecov
prior
rna
extract
extern
standard
exact
mimic
true
target
subject
experiment
procedur
provid
extern
standard
correct
differ
effici
rna
extract
rtpcr
furthermor
facilit
eas
sampl
handl
method
base
quantif
bvdv
rna
per
volum
frozen
whole
blood
five
holsteinfriesian
calv
rang
age
month
obtain
bvdv
freesuppli
test
confirm
bvdvfree
statu
antigen
antibodi
elisa
calv
hous
purposebuilt
barn
appropri
biosecur
measur
place
avoid
exposur
adventiti
pathogen
initi
acclimatis
period
calv
challeng
intranas
tcid
viru
earli
passag
kindli
donat
vla
weybridg
uk
edta
blood
sampl
taken
appropri
day
postchalleng
process
viru
isol
realtim
pcr
edta
blood
sampl
taken
virolog
prepar
lysi
erythrocyt
use
ammonium
chlorid
lysi
buffer
sampl
subsequ
pellet
wash
describ
nobiron
et
al
detect
bvdv
sampl
dilut
mainten
medium
seed
duplic
onto
freshli
prepar
foetal
bovin
lung
fbl
cell
incub
day
c
co
one
round
freez
thaw
dilut
materi
inoculum
pass
onto
fbl
previous
seed
onto
coverslip
incub
day
presenc
viru
detect
via
immunofluoresc
stain
use
bvdv
hyperimmun
serum
antibovin
antibodi
score
perform
use
fluoresc
microscop
appropri
filter
set
rna
extract
frozen
whole
blood
allow
sampl
sever
differ
time
point
process
day
use
qiaamp
dna
blood
mini
kit
qiagen
dna
blood
mini
kit
use
sever
modif
made
discuss
supplier
enabl
purif
rna
frozen
whole
blood
viral
rna
kit
abl
process
frozen
blood
sampl
first
l
blood
thaw
l
cecov
tcid
ml
ad
extern
rna
refer
ad
l
proteas
solut
follow
l
buffer
al
incub
c
min
sampl
cool
l
ethanol
ad
appli
spin
column
two
wash
rna
elut
l
tissu
cultur
grade
dh
invitrogen
rna
reversetranscrib
use
superscript
ii
invitrogen
random
primer
amersham
pharmacia
biotech
sybr
green
dye
use
realtim
rtpcr
method
bind
doubl
strand
dna
produc
reaction
reaction
contain
l
sybr
green
jumpstart
taq
readymix
qpcr
sigma
l
forward
primer
pmoll
l
revers
primer
pmoll
l
templat
cdna
sampl
analys
triplic
pcr
condit
c
min
follow
cycl
c
c
c
c
plate
read
taken
reaction
carri
dna
engin
opticon
mj
research
data
analys
use
opticon
monitor
analysi
softwar
version
primer
design
amplifi
bp
region
bvdv
utr
sens
tagtcgtcagtggttcacgcc
antisens
cctctgcagcaccctatcag
bp
region
cecov
nucleocapsid
gene
sens
ctcgtggycggaagagtaat
antisens
gcaacccagamractccatc
test
confirm
sensit
effici
rang
dna
concentr
primer
effici
confirm
experi
use
formula
primer
effici
pfaffl
wherebi
valu
indic
effici
ensur
pcr
product
amplifi
effici
rate
experi
compar
standard
sampl
use
plasmid
dna
contain
bvdv
cecov
pcr
product
clone
pgemt
promega
cdna
potenti
complex
sampl
purifi
plasmid
dna
use
standard
curv
test
carri
confirm
compon
viral
cdna
prepar
would
detriment
pcr
reaction
wherebi
standard
sampl
spike
cdna
uninfect
bovin
blood
cycl
threshold
ct
valu
compar
nonspik
sampl
melt
curv
analysi
pcr
product
also
carri
experi
confirm
primerdim
nonspecif
product
absent
fluoresc
measur
temperatur
bvdv
cecov
specif
amplicon
detect
data
shown
mean
ct
valu
cecov
determin
multipl
extract
cecov
spike
blood
mean
ct
sd
n
sampl
fell
within
rang
mean
cecov
ct
sd
correct
describ
niester
procedur
repeat
sampl
outsid
rang
bvdv
challeng
leucopenia
evid
calv
fig
decreas
white
blood
cell
count
rang
compar
mean
prechalleng
level
anim
day
postchalleng
mean
reduct
statist
signific
day
p
day
p
day
p
demonstr
characterist
leucopenia
observ
follow
acut
bvdv
infect
highlight
complex
face
undertak
realtim
pcr
acut
infect
cattl
normal
cellular
housekeep
gene
primer
design
amplifi
bp
region
highli
conserv
bvdv
utr
linear
utr
assay
confirm
use
cdna
obtain
bvdv
spike
blood
fig
within
rang
ng
ng
sam
ple
contain
tcid
tcid
bvdv
indic
sensit
techniqu
pcr
effici
regress
coeffici
possibl
effici
detect
viru
sampl
contain
less
tcid
bvdv
linear
primer
viru
isol
buffi
coat
perform
immunofluoresc
assay
two
passag
fbl
cell
also
confirm
use
plasmid
dna
contain
utr
pcr
product
fig
use
gener
utr
standard
curv
experi
linear
rang
pcr
dna
copiesl
effici
regress
coeffici
spike
plasmid
dna
standard
cdna
obtain
bvdv
neg
anim
detriment
effici
reaction
fig
statist
signific
differ
ct
valu
obtain
plasmid
compar
cdna
spike
plasmid
p
linear
rang
cecov
primer
also
assess
use
cdna
obtain
sampl
contain
tcid
cecov
effici
regress
coeffici
data
shown
bvdv
plasmid
standard
curv
rang
copiesl
use
assess
utr
copi
number
sampl
pcr
effici
experi
regress
coeffici
greater
data
shown
utr
ct
valu
adjust
accordingli
base
ct
valu
cecov
reaction
standard
viru
isol
one
anim
calf
viru
neg
throughout
studi
period
viru
could
isol
remain
calv
day
day
postchalleng
viru
isol
anim
day
postinfect
tabl
valid
new
methodolog
two
time
point
chosen
analysi
day
postinfect
repres
peak
viraemia
also
day
repres
stage
viru
isol
indic
anim
viru
free
bvdv
viral
rna
detect
whole
blood
taken
day
postchalleng
everi
calf
fig
estim
viral
genom
copi
number
rang
utr
copiesml
blood
day
respect
viral
rna
copi
per
ml
blood
higher
day
day
three
five
calv
although
differ
statist
signific
calf
p
remain
two
calv
similar
level
viral
rna
day
postinfect
calf
consist
neg
infecti
viru
isol
posit
viral
rna
time
point
test
expect
would
discrep
estim
bvdv
utr
copi
number
viral
rna
infecti
viral
load
studi
result
confirm
rna
copi
correl
num
ber
infecti
genom
present
therefor
potenti
infect
viru
transmiss
lettelli
kerkhof
demonstr
use
bvdv
type
viru
stock
copi
viru
genom
per
infecti
particl
presum
reflect
ratio
infecti
defect
viral
genom
similar
ratio
observ
yellow
fever
viru
bae
et
al
result
current
studi
would
support
observ
vivo
least
propos
although
bvdv
rna
still
detect
infecti
viru
complex
antibodi
therebi
lead
cessat
viraemia
case
calf
viru
neutralis
antibodi
titr
measur
day
data
shown
support
premis
order
compar
sampl
necessari
use
form
standardis
often
housekeep
gene
express
use
achiev
howev
housekeep
gene
express
vari
use
gene
intern
control
care
consid
relat
cell
type
cell
metabol
thellin
et
al
larg
number
public
focus
valid
intern
refer
gene
demonstr
difficulti
select
appropri
candid
inde
mani
author
recommend
use
least
two
dent
et
al
three
bustin
vandesompel
et
al
valid
housekeep
gene
ensur
accuraci
data
addit
use
housekeep
gene
control
variat
rna
extract
cdna
synthesi
difficult
fix
amount
blood
analys
johansson
et
al
normal
rang
leucocyt
count
blood
healthi
cattl
l
blood
thu
demonstr
potenti
threefold
variat
cell
number
furthermor
acut
bvdv
infect
caus
transient
leucopenia
lead
reduct
number
circul
leucocyt
pronounc
viru
virul
well
host
factor
may
result
reduct
white
blood
cell
rang
mild
sever
current
studi
five
calv
challeng
dose
viru
degre
leucopenia
vari
anim
anim
fig
facilit
viru
quantif
per
fix
volum
blood
face
characterist
leucopenia
observ
cattl
acut
bvdv
infect
novel
twostep
realtim
rtpcr
method
utilis
extern
rna
refer
standard
develop
second
rna
viru
canin
enter
coronaviru
cecov
use
control
stage
method
enabl
eas
sampl
handl
method
base
quantif
bvdv
rna
per
volum
frozen
whole
blood
bovin
blood
sampl
spike
known
amount
refer
cecov
prior
rna
extract
coronaviru
coextract
subsequ
amplifi
quantit
manner
enabl
valid
nucleic
acid
isol
amplif
effici
sampl
detect
sampl
sampl
prepar
amplif
fail
determin
signal
gener
cecov
standard
system
spike
sampl
heterolog
viru
use
previous
hepat
c
viru
quantif
cleland
et
al
castelain
et
al
detect
epsteinbar
viru
cytomegaloviru
niester
current
much
interest
control
strategi
bvdv
infect
cattl
end
rapid
reliabl
diagnosi
persist
acut
infect
cattl
imper
molecular
diagnost
method
increasingli
utilis
tool
detect
numer
viral
pathogen
use
realtim
rtpcr
method
establish
presenc
absenc
bvdv
rna
cattl
may
import
implic
futur
diagnost
screen
control
strategi
